|
Re: Research roundup: Docs' views of industry gifts; Chemotherapy payments; Health la
Ok...all of that further supports the notion that competent cell based sensitivity testing for various endocrine agents is needed.
I'm just saying that even the companies that do sensitivity testing seem to leave endocrine considerations underinvestigated.
The question in my mind is why. Are the available procedures not capable? They seem focused on traditional chemos and targeted biologicals.
|